Evidence map›Paper›PMID 31302940›Full record

ReviewJournal of leukocyte biology2019

Secreted IgM: New tricks for an old molecule.

Rebecca Blandino, Nicole Baumgarth

Open access · greenAbstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  2. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Defining the Features of Complement-Active IgM.Journal of molecular biology · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rebecca BlandinoBiochemistry, Molecular, Cellular and Developmental Biology Graduate Group, University of California, Davis, California, USA.
Nicole BaumgarthBiochemistry, Molecular, Cellular and Developmental Biology Graduate Group, University of California, Davis, California, USA.ORCID 0000-0002-2891-4483
University of California, Davis · US

Funding

Virus-induced Cell Fate Decisions in Anti-Viral ImmunityU19AI109962 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LUND, FRANCES E. · 2014 to 2018
$11.6M
UC Davis Biology ProgramR25GM056765 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI GOMES, ALDRIN V. · 1998 to 2019
$9.7M
Protective humoral immunity to influenza infectionR01AI117890 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMGARTH, NICOLE · 2016 to 2020
$2.4M
B-1 cells, IgM and Protective Humoral Immunity to InfluenzaR01AI148652 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMGARTH, NICOLE · 2019 to 2023
$2.4M
Quality Substitution Among Heavy and AUD Drinkers and Alcohol Tax PolicyR01AA017890 · NIAAA · DREXEL UNIVERSITY · PI RICH, JOHN A · 2009 to 2011
$924k
COMPLEMENT: A MEDIATOR OF CELLULAR IMMUNITYR01AI017890 · NIAID · SCRIPPS CLINIC AND RESEARCH FOUNDATION · PI COOPER, NEIL R. · 1985 to 1985
–
NIAAA NIH HHS R01 AA017890NIAID NIH HHS R01 AI117890NIAID NIH HHS R01 AI148652NIAID NIH HHS U19 AI109962NIGMS NIH HHS R25 GM056765
6 · The paper itself

Abstract

Secreted IgM (sIgM) is a multifunctional evolutionary conserved antibody that is critical for the maintenance of tissue homeostasis as well as the development of fully protective humoral responses to pathogens. Constitutive secretion of self- and polyreactive natural IgM, produced mainly by B-1 cells, provides a circulating antibody that engages with autoantigens as well as invading pathogens, removing apoptotic and other cell debris and initiating strong immune responses. Pathogen-induced IgM production by B-1 and conventional B-2 cells strengthens this early, passive layer of IgM-mediated immune defense and regulates subsequent IgG production. The varied effects of secreted IgM on immune homeostasis and immune defense are facilitated through its binding to numerous different cell types via different receptors. Recent studies identified a novel function for pentameric IgM, namely as a transporter for the effector protein ″apoptosis-inhibitor of macrophages″ (AIM/CD5L). This review aims to provide a summary of the known functions and effects of sIgM on immune homeostasis and immune defense, and its interaction with its various receptors, and to highlight the many critical immune regulatory functions of this ancient and fascinating immunoglobulin.

Indexed as

AnimalsB-Lymphocyte SubsetsHomeostasisHumansImmunoglobulin MImmunoglobulin Msecretory IgMAIMautoimmunityFcµRhomeostasisinflammationsecreted IgM

Identifiers

PMID31302940
PMCPMC6803036
OpenAlexW2956865286

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.